Annex Advisory Services’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.51M | Sell |
12,459
-529
| -4% | -$181K | 0.08% | 109 |
|
|
2026
Q1 | $4.57M | Buy |
12,988
+231
| +2% | +$82.3K | 0.09% | 110 |
|
|
2025
Q4 | $4.18M | Buy |
12,757
+1,905
| +18% | +$604K | 0.08% | 115 |
|
|
2025
Q3 | $3.06M | Sell |
10,852
-378
| -3% | -$110K | 0.07% | 114 |
|
|
2025
Q2 | $3.14M | Buy |
11,230
+85
| +0.8% | +$24.1K | 0.08% | 112 |
|
|
2025
Q1 | $3.47M | Sell |
11,145
-4,623
| -29% | -$1.37M | 0.1% | 97 |
|
|
2024
Q4 | $4.11M | Sell |
15,768
-2,027
| -11% | -$601K | 0.12% | 93 |
|
|
2024
Q3 | $5.73M | Sell |
17,795
-336
| -2% | -$110K | 0.18% | 81 |
|
|
2024
Q2 | $5.66M | Buy |
18,131
+3,040
| +20% | +$893K | 0.2% | 77 |
|
|
2024
Q1 | $4.29M | Buy |
15,091
+285
| +2% | +$83.4K | 0.15% | 83 |
|
|
2023
Q4 | $4.26M | Buy |
+14,806
| New | +$4.03M | 0.18% | 82 |
|
|
2023
Q1 | – | Sell |
-876
| Closed | -$230K | – | 244 |
|
|
2022
Q4 | $230K | Buy |
+876
| New | +$235K | 0.01% | 221 |
|
|
2022
Q3 | – | Sell |
-854
| Closed | -$208K | – | 241 |
|
|
2022
Q2 | $208K | Buy |
+854
| New | +$209K | 0.02% | 236 |
|
|
2021
Q4 | – | Sell |
-944
| Closed | -$201K | – | 251 |
|
|
2021
Q3 | $201K | Sell |
944
-13,457
| -93% | -$3.1M | 0.02% | 204 |
|
|
2021
Q2 | $3.51M | Buy |
14,401
+657
| +5% | +$162K | 0.28% | 59 |
|
|
2021
Q1 | $3.42M | Buy |
13,744
+764
| +6% | +$182K | 0.33% | 56 |
|
|
2020
Q4 | $2.98M | Buy |
12,980
+681
| +6% | +$157K | 0.29% | 54 |
|
|
2020
Q3 | $3.13M | Buy |
12,299
+20
| +0.2% | +$4.96K | 0.4% | 30 |
|
|
2020
Q2 | $2.9M | Buy |
12,279
+623
| +5% | +$142K | 0.4% | 29 |
|
|
2020
Q1 | $2.36M | Buy |
11,656
+1,021
| +10% | +$223K | 0.33% | 32 |
|
|
2019
Q4 | $2.56M | Buy |
10,635
+421
| +4% | +$92.8K | 0.31% | 42 |
|
|
2019
Q3 | $1.98M | Buy |
10,214
+268
| +3% | +$51.4K | 0.27% | 46 |
|
|
2019
Q2 | $1.83M | Sell |
9,946
-65
| -0.6% | -$11.6K | 0.26% | 45 |
|
|
2019
Q1 | $1.9M | Sell |
10,011
-146
| -1% | -$27.9K | 0.29% | 40 |
|
|
2018
Q4 | $1.98M | Buy |
10,157
+678
| +7% | +$132K | 0.31% | 43 |
|
|
2018
Q3 | $1.97M | Buy |
9,479
+457
| +5% | +$90.1K | 0.3% | 44 |
|
|
2018
Q2 | $1.67M | Buy |
9,022
+575
| +7% | +$102K | 0.28% | 42 |
|
|
2018
Q1 | $1.44M | Buy |
8,447
+897
| +12% | +$165K | 0.26% | 44 |
|
|
2017
Q4 | $1.31M | Buy |
7,550
+398
| +6% | +$70.4K | 0.25% | 43 |
|
|
2017
Q3 | $1.33M | Buy |
7,152
+367
| +5% | +$65K | 0.27% | 33 |
|
|
2017
Q2 | $1.17M | Buy |
6,785
+1,022
| +18% | +$166K | 0.26% | 33 |
|
|
2017
Q1 | $946K | Sell |
5,763
-1,127
| -16% | -$187K | 0.24% | 36 |
|
|
2016
Q4 | $1.01M | Buy |
6,890
+2,276
| +49% | +$343K | 0.24% | 32 |
|
|
2016
Q3 | $770K | Sell |
4,614
-88
| -2% | -$14.9K | 0.2% | 40 |
|
|
2016
Q2 | $715K | Buy |
4,702
+96
| +2% | +$14.9K | 0.19% | 43 |
|
|
2016
Q1 | $691K | Sell |
4,606
-63
| -1% | -$9.36K | 0.2% | 43 |
|
|
2015
Q4 | $758K | Buy |
4,669
+339
| +8% | +$53.3K | 0.22% | 32 |
|
|
2015
Q3 | $599K | Buy |
4,330
+928
| +27% | +$146K | 0.19% | 36 |
|
|
2015
Q2 | $522K | Buy |
3,402
+847
| +33% | +$136K | 0.17% | 38 |
|
|
2015
Q1 | $408K | Buy |
2,555
+577
| +29% | +$90.9K | 0.13% | 49 |
|
|
2014
Q4 | $315K | Buy |
+1,978
| New | +$308K | 0.1% | 66 |
|
Other funds holding AMGN
FFM
SP
Annex Advisory Services's AMGN Position: Q2 2026 in Review
Annex Advisory Services reduced its Amgen (AMGN) stake by 4.1% in Q2 2026, selling an estimated $181K and leaving 12,459 shares worth $4.51M. The position accounts for 0.08% of the portfolio, ranked #109.
Annex Advisory Services first reported a position in AMGN in Q4 2014 and has held it in 41 quarters since. The position peaked at $5.73M in Q3 2024. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Annex Advisory Services held 12,459 shares of Amgen worth $4.51M as of Q2 2026.
- Annex Advisory Services sold 529 Amgen shares in Q2 2026, an estimated $181K.
- Amgen made up 0.08% of Annex Advisory Services's portfolio in Q2 2026, its #109 holding.
- Annex Advisory Services first reported a position in Amgen in Q4 2014 and has held it in 41 quarters since.
- Annex Advisory Services's Amgen position peaked at $5.73M in Q3 2024.
- 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Annex Advisory Services's 13F filing for Q2 2026, filed 10 Jul 2026.